Toggle navigation
Home
Search
Services
Blog
Contact
About
Human Monoclonal Antibodies
Hwang, Kou M.
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 5 grants from Kou Hwang
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Gating Mechanism of NMDA receptors
Immune responses in traumatic RGC death
This Two-Part Cooperative Agreement Funds Activities Directly Related to Hepatiti
Interactive Image Guided Closed Loop Thermal Therapy
In Vivo Measuring of Anterior Cruciate Ligament Strain
Recently added grants:
Long Acting Film Technology for Contraception and HIV Prevention (LATCH)
How immunodominant Fc peptide epitopes expand natural regulatory T cells and downregulate inflammation
B-cell-specific transduction for anti-HIV antibody and B-cell receptor expression
Identification of complex cellular phenotypes and their interactions in MS lesions
Adenovirus Types and Acute Respiratory Illness Severity in Children
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067938-000
Application #
3614575
Study Section
Project Start
1986-09-18
Project End
Budget Start
1986-09-18
Budget End
1987-03-31
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Related projects
NIH 1987
N43 CM
Human Monoclonal Antibodies
Hwang, Kou M. / Genelabs Technologies, Inc.
NIH 1986
N43 CM
Human Monoclonal Antibodies
Hwang, Kou M. / Genelabs Technologies, Inc.
Comments
Be the first to comment on this grant